Nasal nitric oxide May not differentiate primary ciliary dyskinesia from certain primary immunodeficiencies

Pediatr Pulmonol. 2022 Sep;57(9):2269-2272. doi: 10.1002/ppul.25989. Epub 2022 Jun 2.

Abstract

The diagnosis of primary ciliary dyskinesia (PCD) is made through a combination of clinical features supported by a panel of diagnostic tests. Our cases highlight the similarities in the clinical presentation of patients with the specific immunodeficiency activated phosphatidylinositol 3-kinase delta syndrome 1 (or PIK3CD-related disorder) and PCD. We highlight the importance of repeating nasal nitric oxide testing when PCD has not been confirmed by genetic or ciliary electron micrograph analysis in the setting of an expanded suppurative lung disease differential that includes considerations for immunodeficiency as well as PCD.

Keywords: nasal nitric oxide; primary ciliary dyskinesia; primary immunodeficiency.

Publication types

  • Letter

MeSH terms

  • Ciliary Motility Disorders* / diagnosis
  • Humans
  • Kartagener Syndrome* / diagnosis
  • Nitric Oxide
  • Nose

Substances

  • Nitric Oxide